
Metformin (500mg)
Active composition
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Metfra 500mg Tablet contains Metformin hydrochloride, an oral antihyperglycemic agent used primarily in the management of type 2 diabetes mellitus. Metformin belongs to the biguanide class and acts by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. This multifaceted mechanism helps to achieve better glycemic control without causing significant hypoglycemia when used as monotherapy. Metfra 500mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, particularly in overweight patients or those with insulin resistance. It may be used alone or in combination with other antidiabetic agents or insulin. The medication should be administered with meals to reduce gastrointestinal side effects such as nausea, vomiting, diarrhea, and abdominal discomfort. Caution is advised in patients with renal impairment, hepatic dysfunction, or conditions predisposing to hypoxia, as these increase the risk of lactic acidosis, a rare but serious adverse effect. Regular monitoring of renal function and blood glucose levels is recommended during therapy. Metfra 500mg should be used under medical supervision, with lifestyle modifications including diet and exercise for optimal therapeutic outcomes.
Biguanides Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Metfra 500mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
High Risk
Metfra 500mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Medical Advice
Metfra 500mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Metfra 500mg Tablet may be needed. Please consult your doctor. Use of Metfra 500mg Tablet is, however, not recommended in patients with severe kidney disease.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Metfra 500mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Metfra 500mg Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Metfra 500mg Tablet

Metformin (500mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Metfra 500mg Tablet contains Metformin hydrochloride, an oral antihyperglycemic agent used primarily in the management of type 2 diabetes mellitus. Metformin belongs to the biguanide class and acts by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. This multifaceted mechanism helps to achieve better glycemic control without causing significant hypoglycemia when used as monotherapy. Metfra 500mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, particularly in overweight patients or those with insulin resistance. It may be used alone or in combination with other antidiabetic agents or insulin. The medication should be administered with meals to reduce gastrointestinal side effects such as nausea, vomiting, diarrhea, and abdominal discomfort. Caution is advised in patients with renal impairment, hepatic dysfunction, or conditions predisposing to hypoxia, as these increase the risk of lactic acidosis, a rare but serious adverse effect. Regular monitoring of renal function and blood glucose levels is recommended during therapy. Metfra 500mg should be used under medical supervision, with lifestyle modifications including diet and exercise for optimal therapeutic outcomes.
Biguanides Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Metfra 500mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
High Risk
Metfra 500mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Medical Advice
Metfra 500mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Metfra 500mg Tablet may be needed. Please consult your doctor. Use of Metfra 500mg Tablet is, however, not recommended in patients with severe kidney disease.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Metfra 500mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Metfra 500mg Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Metfra 500mg Tablet













